AT333091T

Method for measurement of blood substitutes

Abstract

(57) They are identification and the method of quantifying in summary serum or the blood substitute in a plasma sample, for example, the concentration of bridge construction hemoglobin, quickly and correctly. By this method, the influence of a blood substitute is rectified to the analysis thing concentration measured using the measurement concentration of a blood substitute, for example, serum / plasma whole protein. By this method, the concentration of the true hemoglobin under existence of a blood substitute can be determined. This method is performed by the blood analytical instrument to the sample included all over the tube with the 1st or 2nd label used for distributing serum or plasma, or a pipette tip.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

24 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
3855497United States of AmericaP

Members24

Family members, oldest first
DocumentOfficeKind
CA2283154A1CanadaA1
WO9838961A1World Intellectual Property Organization (WIPO)A1
WO9839634A1World Intellectual Property Organization (WIPO)A1
EP0967954A1European Patent Office (EPO)A1
EP1023583A1European Patent Office (EPO)A1
US6268910B1United States of AmericaB1
JP2001513892AJapanA
JP2001514744AJapanA
US2002167667A1United States of AmericaA1
US2002186363A1United States of AmericaA1
US6995835B2United States of AmericaB2
EP0967954B1European Patent Office (EPO)B1
EP1023583B1European Patent Office (EPO)B1
AT332118TAustriaT
ATE332118T1AustriaT1
AT333091TThis recordAustriaT
ATE333091T1AustriaT1
DE69835142D1GermanyD1
DE69736336D1GermanyD1
US7198955B1United States of AmericaB1
JP3918952B2JapanB2
DE69835142T2GermanyT2
DE69736336T2GermanyT2
CA2283154CCanadaC